drugset / Trial / NCT02695446

Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline

NCT02695446

Phase 4 Completed 12 enrolled BioPharmX, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study is to evaluate the skin and plasma concentrations of minocycline in subjects undergoing treatment of acne vulgaris with oral extended release minocycline. Acne lesion counts and safety/tolerance of the treatment will also be evaluated.

Timeline

Start
2016-03
Primary completion
2016-04
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 2 mg/kg Oral

Indications